European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Household Out-of-Pocket Payment by Country

In 2023, Bulgaria led European nations in healthcare expenditure on pharmaceuticals and medical non-durable goods by household out-of-pocket payments at 23.55% of total health expenditure, albeit showing a decline. Emerging economies like Bosnia and Herzegovina and Greece exhibited modest growth, while Cyprus, Finland, and Latvia displayed notable decreases, with Latvia's reduction reaching 20.97%. Established markets such as Germany, France, and the Netherlands maintained lower percentages with minor declines, reinforcing their robust public healthcare systems.

Future trends to monitor include:

• Potential stabilization or declines in countries with existing downward trends, signaling effective public health policies or economic constraints.
• Shifts in healthcare funding policies due to economic pressures and demographic changes, possibly altering out-of-pocket payments.
• Technological advances and pharmaceutical innovations impacting cost structures and household expenditures.